Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. ICRP Publication 96‏‎ (1 revision)
  2. ICRP Publication 130‏‎ (1 revision)
  3. Secondary radiation‏‎ (1 revision)
  4. ICRP Publication 145‏‎ (1 revision)
  5. Intake‏‎ (1 revision)
  6. ICRP Publication 2‏‎ (1 revision)
  7. Standard-size adult‏‎ (1 revision)
  8. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  9. Derived consideration reference level‏‎ (1 revision)
  10. ICRP Publication 40‏‎ (1 revision)
  11. Tissue reaction‏‎ (1 revision)
  12. Measured quantity‏‎ (1 revision)
  13. ICRP Publication 55‏‎ (1 revision)
  14. Dose conversion convention‏‎ (1 revision)
  15. Tumour suppressor gene‏‎ (1 revision)
  16. National DRL‏‎ (1 revision)
  17. ICRP Publication 7‏‎ (1 revision)
  18. ICRP Publication 84‏‎ (1 revision)
  19. Oxygen enhancement ratio‏‎ (1 revision)
  20. Exclusion‏‎ (1 revision)
  21. Population risk‏‎ (1 revision)
  22. Acute exposure‏‎ (1 revision)
  23. Allometry‏‎ (1 revision)
  24. ICRP Publication 102‏‎ (1 revision)
  25. Registry‏‎ (1 revision)
  26. ICRP Publication 116‏‎ (1 revision)
  27. ICRP Publication 97‏‎ (1 revision)
  28. ICRP Publication 131‏‎ (1 revision)
  29. Secretory cells‏‎ (1 revision)
  30. ICRP Publication 146‏‎ (1 revision)
  31. Concentration ratio‏‎ (1 revision)
  32. Intensity-modulated radiotherapy‏‎ (1 revision)
  33. ICRP Publication 20‏‎ (1 revision)
  34. Stem cell‏‎ (1 revision)
  35. Kerma approximation‏‎ (1 revision)
  36. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  37. Derived investigation level‏‎ (1 revision)
  38. ICRP Publication 41‏‎ (1 revision)
  39. Directional dose equivalent‏‎ (1 revision)
  40. ICRP Publication 56‏‎ (1 revision)
  41. Dose conversion factor‏‎ (1 revision)
  42. National radon survey‏‎ (1 revision)
  43. ICRP Publication 70‏‎ (1 revision)
  44. Effect modifier‏‎ (1 revision)
  45. ICRP Publication 85‏‎ (1 revision)
  46. Endosteum‏‎ (1 revision)
  47. Potential alpha energy concentration‏‎ (1 revision)
  48. Redox‏‎ (1 revision)
  49. Biological half-life‏‎ (1 revision)
  50. ICRP Publication 117‏‎ (1 revision)
  51. ICRP Publication 98‏‎ (1 revision)
  52. ICRP Publication 132‏‎ (1 revision)
  53. Clonogenic surviving fraction‏‎ (1 revision)
  54. ICRP Publication 147‏‎ (1 revision)
  55. Cone beam computed tomography‏‎ (1 revision)
  56. Somatic effect‏‎ (1 revision)
  57. ICRP Publication 21‏‎ (1 revision)
  58. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  59. Derived limit‏‎ (1 revision)
  60. Targeted effects‏‎ (1 revision)
  61. ICRP Publication 42‏‎ (1 revision)
  62. ICRP Publication 57‏‎ (1 revision)
  63. Typical value‏‎ (1 revision)
  64. ICRP Publication 71‏‎ (1 revision)
  65. ICRP Publication 86‏‎ (1 revision)
  66. Particle transport‏‎ (1 revision)
  67. Human Alimentary Tract Model‏‎ (1 revision)
  68. ICRP Publication 104‏‎ (1 revision)
  69. Biomarker‏‎ (1 revision)
  70. Relative biological effectiveness‏‎ (1 revision)
  71. ICRP Publication 119‏‎ (1 revision)
  72. ICRP Publication 99‏‎ (1 revision)
  73. ICRP Publication 133‏‎ (1 revision)
  74. Security screening‏‎ (1 revision)
  75. ICRP Publication 148‏‎ (1 revision)
  76. ICRP Publication 22‏‎ (1 revision)
  77. Stochastic effect‏‎ (1 revision)
  78. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  79. Derived reference level‏‎ (1 revision)
  80. ICRP Publication 43‏‎ (1 revision)
  81. Disposal facility‏‎ (1 revision)
  82. Tolerance dose‏‎ (1 revision)
  83. ICRP Publication 58‏‎ (1 revision)
  84. ICRP Publication 72‏‎ (1 revision)
  85. Occupancy factor‏‎ (1 revision)
  86. ICRP Publication 87‏‎ (1 revision)
  87. Absorption Type‏‎ (1 revision - redirect page)
  88. Additional dose‏‎ (1 revision)
  89. Ambient dose equivalent‏‎ (1 revision)
  90. Radon-prone area‏‎ (1 revision)
  91. Human Respiratory Tract Model‏‎ (1 revision)
  92. Automatic exposure control‏‎ (1 revision)
  93. Reference Person‏‎ (1 revision)
  94. ICRP Publication 105‏‎ (1 revision)
  95. Relative life lost‏‎ (1 revision)
  96. ICRP Publication 12‏‎ (1 revision)
  97. Ring chromosome‏‎ (1 revision)
  98. ICRP Supporting Guidance 2‏‎ (1 revision)
  99. ICRP Publication 134‏‎ (1 revision)
  100. Cobblestone area forming cell assay‏‎ (1 revision)
  101. ICRP Publication 149‏‎ (1 revision)
  102. International Commission on Radiological Protection‏‎ (1 revision)
  103. ICRP Publication 23‏‎ (1 revision)
  104. DRL quantity‏‎ (1 revision)
  105. Lag‏‎ (1 revision)
  106. ICRP Publication 30 (Supplement to Part 1)‏‎ (1 revision)
  107. Designated area‏‎ (1 revision)
  108. Teratocarcinoma‏‎ (1 revision)
  109. Low dose‏‎ (1 revision)
  110. ICRP Publication 44‏‎ (1 revision)
  111. Distribution coefficient‏‎ (1 revision)
  112. ICRP Publication 59‏‎ (1 revision)
  113. ICRP Publication 73‏‎ (1 revision)
  114. ICRP Publication 88‏‎ (1 revision)
  115. Epigenetic effects‏‎ (1 revision)
  116. 1928 Recommendations‏‎ (1 revision)
  117. Potentially lethal damage repair‏‎ (1 revision)
  118. Additive risk projection model‏‎ (1 revision)
  119. ICRP Publication 106‏‎ (1 revision)
  120. Relative risk‏‎ (1 revision)
  121. ICRP Publication 120‏‎ (1 revision)
  122. Carers and comforters‏‎ (1 revision)
  123. ICRP Publication 135‏‎ (1 revision)
  124. ICRP Publication 15‏‎ (1 revision)
  125. Source region‏‎ (1 revision)
  126. ICRP Publication 24‏‎ (1 revision)
  127. Late normal tissue responses‏‎ (1 revision)
  128. ICRP Publication 30 (Supplement to Part 2)‏‎ (1 revision)
  129. Detector quantum efficiency‏‎ (1 revision)
  130. ICRP Publication 45‏‎ (1 revision)
  131. ICRP Publication 6‏‎ (1 revision)
  132. ICRP Publication 74‏‎ (1 revision)
  133. Α/β value‏‎ (1 revision)
  134. Oncogene‏‎ (1 revision)
  135. ICRP Publication 89‏‎ (1 revision)
  136. Exogenous excretion‏‎ (1 revision)
  137. 1931 Recommendations‏‎ (1 revision)
  138. Adenoma‏‎ (1 revision)
  139. ICRP Publication 107‏‎ (1 revision)
  140. Relative survival‏‎ (1 revision)
  141. ICRP Publication 121‏‎ (1 revision)
  142. Case–control study‏‎ (1 revision)
  143. ICRP Publication 136‏‎ (1 revision)
  144. Collective dose‏‎ (1 revision)
  145. Severe deterministic injury‏‎ (1 revision)
  146. ICRP Publication 150‏‎ (1 revision)
  147. Intervention‏‎ (1 revision)
  148. ICRP Publication 25‏‎ (1 revision)
  149. Sublethal damage repair‏‎ (1 revision)
  150. ICRP Publication 31‏‎ (1 revision)
  151. Deterministic effect‏‎ (1 revision)
  152. ICRP Publication 46‏‎ (1 revision)
  153. Transfer of risk‏‎ (1 revision)
  154. Molecular imaging‏‎ (1 revision)
  155. ICRP Publication 60‏‎ (1 revision)
  156. Dose modifying factor‏‎ (1 revision)
  157. Noise‏‎ (1 revision)
  158. ICRP Publication 75‏‎ (1 revision)
  159. ΓH2AX foci‏‎ (1 revision)
  160. Operating management‏‎ (1 revision)
  161. ICRP Publication 9‏‎ (1 revision)
  162. Pencil beam‏‎ (1 revision)
  163. 1934 Recommendations‏‎ (1 revision)
  164. Practice‏‎ (1 revision)
  165. Access control‏‎ (1 revision)
  166. General Information: Radon‏‎ (1 revision - redirect page)
  167. ICRP Publication 108‏‎ (1 revision)
  168. Brachytherapy‏‎ (1 revision)
  169. ICRP Publication 122‏‎ (1 revision)
  170. Risk model‏‎ (1 revision)
  171. ICRP Publication 137‏‎ (1 revision)
  172. Sheltering‏‎ (1 revision)
  173. Induced genomic instability‏‎ (1 revision)
  174. ICRP Publication 151‏‎ (1 revision)
  175. ICRP Publication 26‏‎ (1 revision)
  176. DS86‏‎ (1 revision)
  177. Licensee‏‎ (1 revision)
  178. ICRP Publication 32‏‎ (1 revision)
  179. Thermodynamic diameter‏‎ (1 revision)
  180. Low linear energy transfer radiation‏‎ (1 revision)
  181. ICRP Publication 47‏‎ (1 revision)
  182. ICRP Publication 61‏‎ (1 revision)
  183. Nominal risk coefficient‏‎ (1 revision)
  184. ICRP Publication 76‏‎ (1 revision)
  185. Equilibrium equivalent concentration‏‎ (1 revision)
  186. Expanded radiation field‏‎ (1 revision)
  187. 1937 Recommendations‏‎ (1 revision)
  188. Quality control testing‏‎ (1 revision)
  189. Adventitious source‏‎ (1 revision)
  190. Radioactive waste‏‎ (1 revision)
  191. Annual intake‏‎ (1 revision)
  192. ICRP Publication 109‏‎ (1 revision)
  193. ICRP Publication 123‏‎ (1 revision)
  194. Charged-particle equilibrium‏‎ (1 revision)
  195. ICRPædia Guide to Radiological Protection in Healthcare‏‎ (1 revision - redirect page)
  196. ICRP Publication 138‏‎ (1 revision)
  197. Collimation‏‎ (1 revision)
  198. Shielding‏‎ (1 revision)
  199. ICRP Publication 152‏‎ (1 revision)
  200. ICRP Publication 27‏‎ (1 revision)
  201. Superposition principle‏‎ (1 revision)
  202. Life Span Study‏‎ (1 revision)
  203. ICRP Publication 33‏‎ (1 revision)
  204. Detriment-adjusted risk‏‎ (1 revision)
  205. Thoracic airways‏‎ (1 revision)
  206. ICRP Publication 48‏‎ (1 revision)
  207. Dose-response function‏‎ (1 revision)
  208. Multifactorial diseases‏‎ (1 revision)
  209. ICRP Publication 62‏‎ (1 revision)
  210. Nominal value‏‎ (1 revision)
  211. ICRP Publication 77‏‎ (1 revision)
  212. Equilibrium factor‏‎ (1 revision)
  213. 1950 Recommendations‏‎ (1 revision)
  214. Backscatter factor‏‎ (1 revision)
  215. ICRP Publication 10A‏‎ (1 revision)
  216. ICRP Publication 124‏‎ (1 revision)
  217. ICRP Publication 139‏‎ (1 revision)
  218. ICRP Publication 153‏‎ (1 revision)
  219. ICRP Publication 28‏‎ (1 revision)
  220. Supervised area‏‎ (1 revision)
  221. ICRP Publication 34‏‎ (1 revision)
  222. Thoron progeny‏‎ (1 revision)
  223. ICRP Publication 49‏‎ (1 revision)
  224. Transgenerational effect‏‎ (1 revision)
  225. ICRP Publication 63‏‎ (1 revision)
  226. Non-homologous end joining‏‎ (1 revision)
  227. ICRP Publication 78‏‎ (1 revision)
  228. Elemental dose‏‎ (1 revision)
  229. Optimisation of protection‏‎ (1 revision)
  230. Exposed individuals‏‎ (1 revision)
  231. 1954 Recommendations‏‎ (1 revision)
  232. Quasi-threshold dose‏‎ (1 revision)
  233. Apoptosis‏‎ (1 revision)
  234. Radon progeny‏‎ (1 revision)
  235. Reference parameter value‏‎ (1 revision)
  236. ICRP Publication 11‏‎ (1 revision)
  237. ICRP Publication 125‏‎ (1 revision)
  238. ICRP Publication 14‏‎ (1 revision)
  239. Commissioning‏‎ (1 revision)
  240. Size-specific dose estimate‏‎ (1 revision)
  241. ICRP Publication 154‏‎ (1 revision)
  242. Cosmic radiation‏‎ (1 revision)
  243. Specific absorbed fraction‏‎ (1 revision)
  244. ICRP Publication 29‏‎ (1 revision)
  245. Surface contamination‏‎ (1 revision)
  246. ICRP Publication 35‏‎ (1 revision)
  247. ICRP Publication 5‏‎ (1 revision)
  248. Dose-threshold hypothesis‏‎ (1 revision)
  249. Translocation‏‎ (1 revision)
  250. Multistage carcinogenesis model‏‎ (1 revision)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)